1 story in this blend

Pharmaceutical research presented at a longevity conference indicates that GLP-1 weight loss drugs may reduce biological age markers. Researchers used machine learning models trained on blood sample datasets to estimate cellular age across thousands of trial subjects. Results showed patients taking active medication scored several years younger biologically than those on placebo, though benefits for non diabetic adults remain unproven.